- Byrna Technologies Inc (NASDAQ:BYRN) reported a second-quarter revenue decline of 13.3% year-over-year to $11.62 million, marginally missing the consensus of $11.67 million.
- Adjusted EPS loss was $(0.05), below the consensus of $(0.03).
- The gross margin contracted by 372 bps to 52.7%.
- Byrna reported a loss from operations of $(2.62) million, compared to a profit of $2.02 million a year ago.
- Adjusted EBITDA loss totaled $(0.909) million, compared to a profit of $2.85 million in 2Q21.
- Order backlog as of May 31, 2022, was $0.8 million.
- The company repurchased ~1.48 million shares of common stock for $12.3 million during the quarter.
- BYRN held cash and equivalents of $25.8 million as of May 31, 2022.
- FY22 Outlook reiterated: Byrna expects revenue of $55 million- $60 million, above the consensus of $54.42 million.
- Price Action: BYRN shares are trading higher by 6.16% at $9.13 on the last check Thursday.
Apollo Medical Holdings Q4 EPS $(0.06) Beats $(0.09) Estimate, Sales $294.21M Beat $245.85M Estimate
Apollo Medical Holdings (NASDAQ:AMEH) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.09) by 33.33 percent. This is a 120 percent decrease over earnings of $0.30 per share
